EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?

Fengyi Jin iD, I Mary Poynten iD, Richard J Hillman, Carmella Law, Monica Molano, Christopher K Fairley, Suzanne M Garland, David J Templeton, Andrew E Grulich, Jennifer Roberts iD, SPANC study team

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Fengyi Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Anus Neoplasms, Papillomavirus Infections, Triage, Early Detection of Cancer. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Cancer Council NSW, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anal high‐risk human papillomavirus (HRHPV) testing‐based anal cancer screening gay and bisexual men (GBM) is associated with high sensitivity, but low specificity. We report the potential role of triage use of anal cytology with HRHPV testing in detecting 12‐month persistent anal high‐grade squamous epithelial lesions (HSIL) in a cohort of GBM in Sydney, Australia. Participants were GBM from the Study of the Prevention of Anal Cancer (SPANC) who underwent annual anal HPV testing, cytology, and high‐resolution anoscopy (HRA)‐guided histology. The sensitivity and specificity of five screening algorithms based on HRHPV test results with triage use of anal cytology (atypical squamous cells of undetermined significance (ASCUS) and atypical squamous cells, cannot exclude HSIL (ASC‐H) used as referral thresholds) were compared to these of HRHPV testing and anal cytology alone. A total of 475 men who had valid HRHPV, cytological, and histological results at both baseline and first annual follow‐up visits were included, median age 49 years (inter‐quartile range: 43–56) and 173 (36.4%) GBM with human immunodeficiency virus. Of all triage algorithms assessed, two had comparable sensitivity with HRHPV testing alone in detecting persistent anal HSIL, but ~20% higher specificity and 20% lower HRA referral rates. These two algorithms involved the immediate referral of those with HPV16 and for those with non‐16 HRHPV either immediate or delayed (for 12 months) referral, depending on cytology result at baseline. Triage use of anal cytology in GBM testing positive for anal HRHPV increases specificity and reduces referral rates while maintaining high sensitivity in detection of HSIL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsPapillomavirus InfectionsTriageEarly Detection of CancerHomosexuality, MaleHumansMaleMiddle AgedAdultAnal CanalSexual and Gender MinoritiesPapillomaviridaeSensitivity and SpecificityBisexualityAustraliaHuman Papillomavirus Viruses

Stichwörter der Autor:innen

anal cancercancer screeninghomosexualityhuman papillomavirusmalescreening performance

Autor:innen und Institutionen

  • The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Dysplasia and Anal Cancer Services, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Centre Women's Infectious Diseases Research, Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  • Melbourne Sexual Health Centre, and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Department of Sexual Health Medicine, Sydney Local Health District, Sydney, New South Wales, Australia.

ORCID-Profile: Fengyi Jin, I Mary Poynten, Jennifer Roberts

Förderung

  • National Health and Medical Research Council
  • Cancer Council NSW
  • Medical Research Council

Zitieren

APA

Jin, F., Poynten, I. M., Hillman, R. J., Law, C., Molano, M., Fairley, C. K., Garland, S. M., Templeton, D. J., Grulich, A. E., Roberts, J., & SPANC study team (2025). Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?. International Journal of Cancer. https://doi.org/10.1002/ijc.35185

Vancouver

Jin F, Poynten IM, Hillman RJ, Law C, Molano M, Fairley CK, et al. Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?. International Journal of Cancer. 2025. doi:10.1002/ijc.35185

BibTeX
@article{Jin2025,
  author = {Jin, Fengyi and Poynten, I Mary and Hillman, Richard J and Law, Carmella and Molano, Monica and Fairley, Christopher K and Garland, Suzanne M and Templeton, David J and Grulich, Andrew E and Roberts, Jennifer and SPANC study team, SPANC study team},
  title = {Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35185}
}
Kostenlos starten →